Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Orna Therapeutics (US)

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. oRNA has many advantages over traditional mRNA approaches, including simplified production, improved formulatability, and superior protein expression – making it a highly disruptive, new class of RNA therapeutics with vast potential to change patient’s lives. *

 

Period Start 2019-01-01 established (s-off)
  Predecessor MIT (Massachusetts Institute of Technology)
Products Industry circular RNA therapeutic, synthetic (fully engineered) (oRNA)
  Industry 2 RNA technology
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 620 Memorial Drive
2nd Floor
  City 02139 Cambridge, MA
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Orna Therapeutics. (2/24/21). "Press Release: Orna Therapeutics Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies". Cambridge, MA.
     
   
Record changed: 2024-01-20

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Orna Therapeutics (US)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top